POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OMW_D_TE4D202_1 (BETA-LACTOGLOBULIN)	3ctt	MALTASE-GLUCOAMYLASE (Homo sapiens)	5 / 9	PRO A 367 GLU A 446 ASN A 201 ALA A 216 SER A 527	None	1.48A	11.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OMW_D_TE4D202_1 (BETA-LACTOGLOBULIN)	3zyj	LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4C (Homo sapiens)	5 / 9	ASN A 208 ASN A 229 ALA A 205 GLN A 252 SER A 253	None	1.38A	16.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OMW_D_TE4D202_1 (BETA-LACTOGLOBULIN)	4h1s	5'-NUCLEOTIDASE (Homo sapiens)	5 / 9	LEU A 191 PRO A 187 ASN A 143 ALA A 199 GLU A 194	None	1.39A	15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	1fyh	INTERFERON GAMMA RECEPTOR 1 (Homo sapiens)	5 / 12	LEU B 185 ILE B 187 ILE B 124 ILE B 117 VAL B 198	None	0.80A	20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	2ro1	TRANSCRIPTION INTERMEDIARY FACTOR 1-BETA (Homo sapiens)	5 / 12	LEU A 740 ILE A 743 VAL A 707 LEU A 788 PHE A 792	None	1.24A	24.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	2ygn	WNT INHIBITORY FACTOR 1 (Homo sapiens)	5 / 12	LEU A  48 VAL A 136 VAL A 134 PHE A  89 MET A  87	PCF  A1179 (-4.1A) None PCF  A1179 ( 4.7A) PCF  A1179 ( 3.8A) PCF  A1179 (-3.6A)	1.06A	18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	2ygo	WNT INHIBITORY FACTOR 1 (Homo sapiens)	5 / 12	LEU A  48 VAL A 136 VAL A 134 PHE A  89 MET A  87	PCF  A1213 (-4.3A) None PCF  A1213 ( 4.6A) PCF  A1213 (-4.1A) PCF  A1213 ( 3.8A)	1.08A	17.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	2z0u	WW DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	ILE A  25 ILE A  61 VAL A  63 VAL A  65 LEU A 130	None	1.10A	20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	2z0u	WW DOMAIN-CONTAINING PROTEIN 1 (Homo sapiens)	5 / 12	ILE A  27 ILE A  61 VAL A  63 VAL A  65 LEU A 130	None	0.82A	20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	3c5h	GLUCOCORTICOID RECEPTOR DNA-BINDING FACTOR 1 (Homo sapiens)	5 / 12	LEU A 178 VAL A 181 LEU A  38 ILE A  33 VAL A 226	None None None GNP  A 301 (-4.3A) None	1.14A	20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	3nzu	PHOSPHATIDYLINOSITOL -4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA ISOFORM (Homo sapiens)	5 / 12	LEU A 987 ILE A 888 ILE A 952 LEU A 911 PHE A 928	None	1.21A	9.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	4gbr	BETA-2 ADRENERGIC RECEPTOR (Homo sapiens)	5 / 12	LEU A 145 VAL A  67 ILE A 127 VAL A 222 LEU A 244	None	1.22A	21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	4lt6	POLY(A) POLYMERASE GAMMA (Homo sapiens)	5 / 12	LEU A  61 LEU A 167 ILE A 165 ILE A 113 VAL A  71	None	1.16A	15.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	4n9f	TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2 (Homo sapiens)	5 / 12	LEU X   5 ILE X   7 ILE X  14 VAL X  24 LEU X  51	None	1.15A	24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	4ov6	PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (Homo sapiens)	5 / 12	LEU B 230 VAL B 233 LEU B 415 VAL B 312 VAL B 310	None	0.92A	19.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	4r0b	GLYCODELIN (Homo sapiens)	6 / 12	LEU A  39 VAL A  41 LEU A  54 ILE A  56 ILE A  84 LEU A 103	None	0.62A	41.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	4rca	SLIT AND NTRK-LIKE PROTEIN 1 (Homo sapiens)	5 / 12	LEU B 252 VAL B 239 ILE B 207 VAL B 197 LEU B 169	None SO4  B 301 (-3.6A) None None None	1.20A	23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	4rca	SLIT AND NTRK-LIKE PROTEIN 1 (Homo sapiens)	5 / 12	VAL B 239 ILE B 207 ILE B 230 VAL B 197 LEU B 169	SO4  B 301 (-3.6A) None None None None	1.10A	23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	4z07	CGMP-DEPENDENT PROTEIN KINASE 1 (Homo sapiens)	5 / 12	LEU A 187 LEU A  96 ILE A 207 ILE A 130 MET A 216	None	1.20A	21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	5jn9	CARBONIC ANHYDRASE 4 (Homo sapiens)	5 / 12	LEU A 182 LEU A  95 ILE A 120 VAL A 148 LEU A 218	None	1.02A	20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	5of4	TFIIH BASAL TRANSCRIPTION FACTOR COMPLEX HELICASE XPD SUBUNIT (Homo sapiens)	5 / 12	LEU B 597 ILE B 595 ILE B 535 ILE B 619 LEU B 558	None	0.93A	12.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y0P_A_TE4A201_1 (BETA-LACTOGLOBULIN)	5tvt	MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE (Homo sapiens)	5 / 12	VAL A 192 LEU A 138 VAL A 112 LEU A 202 PHE A 113	None	1.14A	18.69